Medilines’ role in the advancement of healthcare in the Philippines
One cannot imagine how our healthcare system can cope with the needs of every Filipino, especially that cancer and heart diseases continue to be among the leading causes of death in the Philippines.
This is where Medilines Distributors, Inc., a leading distributor of high-quality medical equipment in the country, comes in. Backed with more than three decades experience in the industry, Medilines Chairman Virgilio B. Villar said the company has been working extensively with the private and public sector to help boost the modernization of hospitals, especially in the detection and treatment of cancer and other serious ailments.
“We are working to make the many advances in healthcare more attainable to Filipinos. Our equipment is at par with global standards and are reliable in detecting and treating a patient’s cancer or other ailment,” said Villar, whose career started as a marketing executive before building his own medical distribution company.
Founded in 2002, Medilines maintains a portfolio of best-in-class equipment from multinational brands such as Siemens (Germany) for diagnostic imaging and Varian (USA) for cancer therapy. The company plans to expand their presence and their product portfolio in the near future to help enhance the country’s healthcare system through quality medical devices.
Medilines carries in its portfolio the MRI, CT scan and PET scan, which help detect and diagnose cardiovascular diseases, early signs of cancer, and other illnesses before treatment.
Medilines also has in its portfolio the medical linear accelerator which is a specialized high energy device used for radiation treatment of cancer patients. A linear accelerator is used to destroy cancer cells by focusing high energy beams on the area of the tumor.
During the pandemic, Medilines provided some of the necessary medical equipment to boost the country’s response to COVID-19 through diagnostic imaging devices such as CT scans and x-rays, which are critical in allowing doctors to determine the extent of COVID-19 infection in patients.